Cargando…

The flavonoid, naringenin, decreases adipose tissue mass and attenuates ovariectomy-associated metabolic disturbances in mice

OBJECTIVE: Adverse metabolic changes associated with loss of ovarian function increase the risk of developing metabolic syndrome and non-alcoholic fatty liver disease (NAFLD) in postmenopausal women. Naringenin improves metabolic disturbances in vitro and in vivo. In the present study, we tested the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ke, Jia-Yu, Kliewer, Kara L, Hamad, Essam M, Cole, Rachel M, Powell, Kimerly A, Andridge, Rebecca R, Straka, Shana R, Yee, Lisa D, Belury, Martha A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350282/
https://www.ncbi.nlm.nih.gov/pubmed/25745505
http://dx.doi.org/10.1186/1743-7075-12-1
_version_ 1782360164825825280
author Ke, Jia-Yu
Kliewer, Kara L
Hamad, Essam M
Cole, Rachel M
Powell, Kimerly A
Andridge, Rebecca R
Straka, Shana R
Yee, Lisa D
Belury, Martha A
author_facet Ke, Jia-Yu
Kliewer, Kara L
Hamad, Essam M
Cole, Rachel M
Powell, Kimerly A
Andridge, Rebecca R
Straka, Shana R
Yee, Lisa D
Belury, Martha A
author_sort Ke, Jia-Yu
collection PubMed
description OBJECTIVE: Adverse metabolic changes associated with loss of ovarian function increase the risk of developing metabolic syndrome and non-alcoholic fatty liver disease (NAFLD) in postmenopausal women. Naringenin improves metabolic disturbances in vitro and in vivo. In the present study, we tested the effects of naringenin on metabolic disturbances resulting from estrogen deficiency in ovariectomized mice. MATERIALS/METHODS: Ovariectomized C57BL/6 J female mice were fed a control diet (10% calories from fat) for 11 weeks. Mice either continued on the control diet (n = 9) or were switched to the control diet supplemented with 3% naringenin (n = 10) for the next 11 weeks. Energy expenditure was measured by indirect calorimetry and activity was monitored by infrared beam breaks. Intra-abdominal and subcutaneous adiposity was evaluated by magnetic resonance imaging (MRI). Blood biochemical measures of metabolic response included glucose, insulin, adipokines, and lipids. Lipid content in liver and muscle and expression of relevant genes in adipose tissue, liver, and muscle were quantified. RESULTS: Ovariectomized mice fed naringenin exhibited lower fasting glucose and insulin levels compared to controls, with over 50% reduction of intra-abdominal and subcutaneous adiposity. Plasma leptin and leptin mRNA in adipose depots were also decreased in mice fed a naringenin diet. Monocyte chemoattractant protein-1 (MCP1/Ccl2) and interleukin 6 (IL-6/Il6) mRNA expression levels were significantly lower in perigonadal adipose tissue of naringenin-supplemented mice. We also observed that mice fed a naringenin diet had less hepatic lipid accumulation with corresponding alterations of hepatic gene expression associated with de novo lipogenesis, fatty acid oxidation, and gluconeogenesis. CONCLUSION: Dietary naringenin attenuates many of the metabolic disturbances associated with ovariectomy in female mice. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1743-7075-12-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4350282
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43502822015-03-06 The flavonoid, naringenin, decreases adipose tissue mass and attenuates ovariectomy-associated metabolic disturbances in mice Ke, Jia-Yu Kliewer, Kara L Hamad, Essam M Cole, Rachel M Powell, Kimerly A Andridge, Rebecca R Straka, Shana R Yee, Lisa D Belury, Martha A Nutr Metab (Lond) Research OBJECTIVE: Adverse metabolic changes associated with loss of ovarian function increase the risk of developing metabolic syndrome and non-alcoholic fatty liver disease (NAFLD) in postmenopausal women. Naringenin improves metabolic disturbances in vitro and in vivo. In the present study, we tested the effects of naringenin on metabolic disturbances resulting from estrogen deficiency in ovariectomized mice. MATERIALS/METHODS: Ovariectomized C57BL/6 J female mice were fed a control diet (10% calories from fat) for 11 weeks. Mice either continued on the control diet (n = 9) or were switched to the control diet supplemented with 3% naringenin (n = 10) for the next 11 weeks. Energy expenditure was measured by indirect calorimetry and activity was monitored by infrared beam breaks. Intra-abdominal and subcutaneous adiposity was evaluated by magnetic resonance imaging (MRI). Blood biochemical measures of metabolic response included glucose, insulin, adipokines, and lipids. Lipid content in liver and muscle and expression of relevant genes in adipose tissue, liver, and muscle were quantified. RESULTS: Ovariectomized mice fed naringenin exhibited lower fasting glucose and insulin levels compared to controls, with over 50% reduction of intra-abdominal and subcutaneous adiposity. Plasma leptin and leptin mRNA in adipose depots were also decreased in mice fed a naringenin diet. Monocyte chemoattractant protein-1 (MCP1/Ccl2) and interleukin 6 (IL-6/Il6) mRNA expression levels were significantly lower in perigonadal adipose tissue of naringenin-supplemented mice. We also observed that mice fed a naringenin diet had less hepatic lipid accumulation with corresponding alterations of hepatic gene expression associated with de novo lipogenesis, fatty acid oxidation, and gluconeogenesis. CONCLUSION: Dietary naringenin attenuates many of the metabolic disturbances associated with ovariectomy in female mice. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1743-7075-12-1) contains supplementary material, which is available to authorized users. BioMed Central 2015-01-13 /pmc/articles/PMC4350282/ /pubmed/25745505 http://dx.doi.org/10.1186/1743-7075-12-1 Text en © Ke et al.; licensee BioMed Central. 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Ke, Jia-Yu
Kliewer, Kara L
Hamad, Essam M
Cole, Rachel M
Powell, Kimerly A
Andridge, Rebecca R
Straka, Shana R
Yee, Lisa D
Belury, Martha A
The flavonoid, naringenin, decreases adipose tissue mass and attenuates ovariectomy-associated metabolic disturbances in mice
title The flavonoid, naringenin, decreases adipose tissue mass and attenuates ovariectomy-associated metabolic disturbances in mice
title_full The flavonoid, naringenin, decreases adipose tissue mass and attenuates ovariectomy-associated metabolic disturbances in mice
title_fullStr The flavonoid, naringenin, decreases adipose tissue mass and attenuates ovariectomy-associated metabolic disturbances in mice
title_full_unstemmed The flavonoid, naringenin, decreases adipose tissue mass and attenuates ovariectomy-associated metabolic disturbances in mice
title_short The flavonoid, naringenin, decreases adipose tissue mass and attenuates ovariectomy-associated metabolic disturbances in mice
title_sort flavonoid, naringenin, decreases adipose tissue mass and attenuates ovariectomy-associated metabolic disturbances in mice
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350282/
https://www.ncbi.nlm.nih.gov/pubmed/25745505
http://dx.doi.org/10.1186/1743-7075-12-1
work_keys_str_mv AT kejiayu theflavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice
AT kliewerkaral theflavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice
AT hamadessamm theflavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice
AT colerachelm theflavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice
AT powellkimerlya theflavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice
AT andridgerebeccar theflavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice
AT strakashanar theflavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice
AT yeelisad theflavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice
AT belurymarthaa theflavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice
AT kejiayu flavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice
AT kliewerkaral flavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice
AT hamadessamm flavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice
AT colerachelm flavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice
AT powellkimerlya flavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice
AT andridgerebeccar flavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice
AT strakashanar flavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice
AT yeelisad flavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice
AT belurymarthaa flavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice